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Mutations in a number of chromatin modifiers are
associated with human neurological disorders.
KDM5C, a histone H3 lysine 4 di- and tri-methyl
(H3K4me2/3)-specific demethylase, is frequently
mutated in X-linked intellectual disability (XLID) pa-
tients. Here, we report that disruption of the mouse
Kdm5c gene recapitulates adaptive and cognitive
abnormalities observed in XLID, including impaired
social behavior, memory deficits, and aggression.
Kdm5c-knockout brains exhibit abnormal dendritic
arborization, spine anomalies, and altered transcrip-
tomes. In neurons, Kdm5c is recruited to promoters
that harbor CpG islands decorated with high levels
of H3K4me3, where it fine-tunes H3K4me3 levels.
Kdm5c predominantly represses these genes, which
include members of key pathways that regulate
the development and function of neuronal circuitries.
In summary, our mouse behavioral data strongly
suggest that KDM5C mutations are causal to
XLID. Furthermore, our findings suggest that loss of
KDM5C function may impact gene expression in
multiple regulatory pathways relevant to the clinical
phenotypes.
INTRODUCTION
Chromatin is composed of repeating units of nucleosomes, each
comprising146 base pairs of DNAwrapped around an octamer1000 Cell Reports 14, 1000–1009, February 9, 2016 ª2016 The Authoof histones H2A, H2B, H3, and H4 (Luger et al., 1997).
Post-translational modifications of histones affect a variety
of chromatin template-based events, including transcription,
replication, and DNA repair (Kouzarides, 2007). Chromatin dys-
regulation has emerged as a major contributor to neurodevelop-
mental (Iwase and Shi, 2010) and psychiatric (Nestler, 2014)
disorders. Intellectual disability (ID) is a prevalent brain disorder,
affecting 1%–2% of the total population, and represents a major
unmet medical need worldwide. ID is defined as limitations in
both adaptive behavior and intellectual functioning (van Bok-
hoven, 2011). Advances in DNA sequencing technologies have
led to the identification of genetic variations associated with
ID, including mutations in many chromatin regulators, e.g.,
genes encoding enzymes that add or remove chemical modifica-
tions from DNA or histone, enzymes that affect nucleosome
positioning, and reader proteins that recognize specific chro-
matinmodifications (Iwase and Shi, 2010). Despite the identifica-
tion of genetic variations associated with different forms of
ID, the cellular and molecular etiology of ID remains poorly
understood.
KDM5C (also known as SMCX and JARID1C) is an X-linked
gene whose protein product belongs to a subfamily of JmjC
domain histone demethylases thatmediate demethylation of his-
tone H3K4me2/3 (Iwase et al., 2007; Tahiliani et al., 2007). Hu-
man genetic studies identified an association between KDM5C
mutations and X-linked ID (XLID), estimated to account for
0.7%–2.8% of all XLID cases (Gonc¸alves et al., 2014; Ropers
and Hamel, 2005). Patient mutations in KDM5C include non-
sense and missense mutations; all patient missense mutations
tested compromise KDM5C’s enzymatic activity, suggesting a
loss-of-function diseasemechanism (Brookes et al., 2015; Iwase
et al., 2007; Tahiliani et al., 2007). In addition to ID (ranging fromrs
mild to severe), many patients with KDM5C mutations exhibit
physical and behavioral abnormalities, including short stature,
epilepsy, aggressive or violent behavior, and constant smiling
(Abidi et al., 2008; Gonc¸alves et al., 2014). Interestingly,
KDM5C has been implicated in other neurological abnormalities,
including ID caused by mutations in ARX (Poeta et al., 2013),
autism spectrum disorder (ASD) (Adegbola et al., 2008; Gon-
c¸alves et al., 2014), Huntington’s disease (Vashishtha et al.,
2013), and cerebral palsy (McMichael et al., 2015), suggesting
that it may be a critical regulator of brain development and func-
tion. KDM5C is ubiquitously expressed, with the highest levels
observed in brain and skeletal muscle in human (Jensen et al.,
2005). In the mouse brain, Kdm5c is broadly expressed in areas
relevant to cognitive and emotional behaviors such as the pre-
frontal cortex, hippocampus, and amygdala (Xu et al., 2008).
However, the role of KDM5C in the central nervous system re-
mains elusive.
The evolutionary conservation of the chromatin machinery and
the genetic nature of the diseases make mice an amenable
model for investigating brain disorders associated with muta-
tions in genes encoding chromatin regulators. For example,
impaired cognitive function in Rubinstein-Taybi syndrome was
recapitulated in mice lacking the histone acetyltransferase
gene Crebbp (Oike et al., 1999), and Kleefstra syndrome was
modeled by targeting Ehmt1, the histone H3K9 methyltransfer-
ase gene (Schaefer et al., 2009). Deletion of murine Kmt2d, an
Mll family H3K4 methyltransferase associated with Kabuki
syndrome, results in craniofacial dysmorphism and cognitive
deficits (Bjornsson et al., 2014). However, no animal model of a
human disorder associated with mutations in a histone methyl-
ation ‘‘eraser’’ gene has been reported, hindering understanding
of the dynamic regulation of histone modification in normal and
diseased brains, and the development of potential therapies.
We therefore generated Kdm5c-knockout (Kdm5c-KO) mice to
test the hypothesis that loss of Kdm5c function is causal to
XLID, to explore the underlying cellular and molecular mecha-
nisms, and to investigate how removal of H3K4me3 by Kdm5c
plays a role in the brain.
RESULTS
We disrupted Kdm5c function in mice through targeted elimi-
nation of exons 11 and 12, which encode its enzymatic domain
(Figures S1A–S1C). This knockout strategy is predicted to
generate a mutant Kdm5c gene encoding an RNA transcript
with an in-frame deletion of exons 11 and 12. Nonetheless,
the predicted mutant Kdm5c protein is barely detectable in
the knockout, and the estimated level of expression is less
than 5% of the WT Kdm5c protein level (Figure S1D; data
not shown). The KDM5C gene is X-linked in humans and
mice, and affected human individuals are predominantly
male; thus, we focused our analyses on male hemizygous an-
imals, namely Kdm5c-knockout mice (/y, KO) and their WT
littermates (+/y, WT). We found that Kdm5c-KO mice exhibited
smaller body size and reduced body weight (Figure 1A; p <
0.005 Student’s t test; Figure S1E), which is reminiscent of
shorter stature in 60% of affected individuals (Abidi et al.,
2008; Jensen et al., 2005). Despite their reduced body weight,Cell RKdm5c-KO male mice are generally in good health and are
fertile.
Kdm5c-KO Mice Exhibit Abnormal Social Behavior,
Including Aggression, and Impaired Learning and
Memory
We next investigated adaptive behaviors that are frequently
compromised in XLID patients. Using the resident-intruder para-
digm, we examined whether KO mice display elevated aggres-
sion, which is reported in one-third of XLID patients with mutated
KDM5C. Kdm5c-KO mice were dramatically more aggressive
than WT littermates. Specifically, the latency of the first attack
to the intruder mouse was significantly shorter for Kdm5c-KO
than WT mice (KO: 12.7 ± 2.4 s, n = 13; WT: 37.6 ± 9.2 s, n =
13; p < 0.05, Student’s t test; Figure 1B). The aggressive
behavior of the KO mice would be categorized as maladaptive
since they often showed little or no interest in social exploration
(e.g., dorsal sniffing) prior to physical attacks and made shorter
pauses between attack episodes (Movies S1 and S2). In fact,
some Kdm5c-KO mice attacked the intruder mouse so viciously
in some sessions that we had to separate them abruptly to pro-
tect the stimulusmice, leading to different trial lengths; therefore,
number of attacks/bites could not be measured. Serum testos-
terone levels were elevated in Kdm5c-KOmice, although the dif-
ference was marginally non-significant (KO: 53.9 ± 13.4 ng/dl,
n = 7; WT: 28.2 ± 4.2, n = 8; p = 0.07, t test; Figure S1F), suggest-
ing that elevated aggression of Kdm5c-KO mice might involve
changes in testosterone level in addition to altered neural
circuitry.
To investigate social behaviors of Kdm5c-KOmice in a neutral
environment, we employed the three-chamber social approach
and memory tests (Silverman et al., 2010). While WT mice spent
significantly more time exploring the stimulus mouse than an
inanimate object, Kdm5c-KO mice spent similar time between
the two (WT: 126.4 ± 13.6 s on stimulus mouse versus 30.9 ±
5.0 s on object, n = 16, p < 0.0001; KO: 87.1 ± 13.2 s on stimulus
mouse versus 55.9 ± 12.5 s on object, p = 0.14; paired t test in
both cases; Figure 1C). The absence of preference for a conspe-
cific is not likely attributable to a sensory discrimination defect,
as both WT and Kdm5c-KO mice preferred the novel over
familiar stimulus mouse in the subsequent social memory tests
(Figure S1G). These data suggest that Kdm5c-KO mice display
a reduced motivation for and/or interest in social interaction
that is intrinsic and governed by genetically programmed neural
circuits (Silverman et al., 2010). This phenotype is consistent with
the manifestation of autistic behaviors in some individuals with
KDM5C mutations (Adegbola et al., 2008).
We then employed the elevated-plus maze paradigm to mea-
sure anxiety levels. Interestingly, compared with WT littermates,
Kdm5c-KO mice spent significantly more time in the open arms
of the maze and significantly less time in the closed arms (Fig-
ure 1D; p < 0.05, Student’s t test), suggesting that Kdm5c-KO
mice have decreased anxiety levels. Of note, in the activity
chamber Kdm5c-KO mice showed increased locomotor activity
during the first 5 min (Figure 1E; p < 0.05, Student’s t test), but
similar activity to WT littermates in subsequent 5 min bins and
over the entire 30-min period (Figures 1E and S1H). This sug-
gests that the reduced anxiety phenotype may also manifesteports 14, 1000–1009, February 9, 2016 ª2016 The Authors 1001
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Figure 1. Kdm5c-KO Mice Are Small, Aggressive, and Show Social Defects
In the initial behavioral study, nine Kdm5c-KO mice (/y, KO) and nine WT littermates (+/y, WT) were analyzed in a blind fashion. Based on power analysis,
additional mice were analyzed for resident-intruder (13 WT, 13 KO) and social approach (16 WT, 14 KO) tests.
(A) Kdm5c-KO mice had a significantly lower body weight at weaning (21 days) and in adulthood.
(B) KO mice showed shorter latencies to attack stimulus mice than WT in the resident-intruder paradigm.
(C) WT but not KO mice spent more time with the stimulus mouse than with an inanimate object (*p < 0.001, paired t test separately for WT and KO) in the social
approach test.
(D) KO mice spent significantly more time in the open arms and less time in the closed arms in the elevated plus maze anxiety test than WT littermates.
(E) Kdm5c-KO mice were more active during the first 5-min period in activity chamber, but showed no difference in any subsequent 5-min bin or overall (30 min).
p values are from Student’s t tests unless otherwise noted (*p < 0.05, **p < 0.005, ***p < 0.0005).as hyperactivity during initial exposure to a novel environment,
i.e., disinhibition or ‘‘boldness.’’ In the open field test, we did
not observe a statistically significant difference between the
two genotypes in the time spent in the center, suggesting that
reduced anxiety of Kdm5c-KO mice is assay dependent (Fig-
ure S1I). It has been suggested that behavioral assays, such as
elevated plus maze, open field, and light-dark exploration, mea-
sure different forms of anxiety, with each being regulated by a set
of partially overlapping genes (Turri et al., 2001). Indeed, it is not
uncommon that a mutation causes an anxiety phenotype in
some tests but not others (van Gaalen and Steckler, 2000).
In order to investigate the cognitive function of Kdm5c-KO
mice, we first carried out fear conditioning, which is commonly
used to assess learning and memory. Kdm5c-KO mice showed
significantly reduced freezing responses upon exposure to the
context or auditory cues, which had been paired with aversive
events (foot shock) 24 hr earlier (Figure 2A; p < 0.005, Student’s
t test). The reduced fear response of Kdm5c-KO mice was also
seen in short-term contextual tests following conditioning in
two independent cohorts, suggesting that Kdm5c is required
for memory acquisition (Figures S2A and S2B). Decreased
freezing behavior is not due to impaired sensory perception, as
Kdm5c-KO animals showed similar responses to WT littermates
in the nociceptive test (Figure 2B).
We also carried out the Morris Water Maze test to characterize
spatial learning. Over a 4-day period with four trials daily,1002 Cell Reports 14, 1000–1009, February 9, 2016 ª2016 The AuthoKdm5c-KOmice showed a significantly slower decline in latency
and longer swimming trajectories to find the platform (p < 0.01,
repeated-measures ANOVA; Figures 2C and S2C). Poor perfor-
mance cannot be attributed to swimming deficiency of Kdm5c-
KO mice because their swimming speed was comparable to
that of WT littermates (Figure 2D). Taken together, these behav-
ioral data demonstrate that Kdm5c is required for the normal
development and/or execution of adaptive, emotional, and
cognitive behaviors.
Kdm5c Is Required for Dendritic Arborization and Spine
Morphology
To determine whether loss of Kdm5c results in behavioral alter-
ations due to changes in overall brain architecture, we per-
formed Nissl staining. We found no gross abnormalities in
the cytoarchitecture of the adult Kdm5c-KO cerebral cortex,
hippocampus, or amygdala (6 months old; Figure 3A), which
are crucial for learning and adaptive behaviors. Further exami-
nation of the neocortex using dendritic marker Map2 and
neuronal subtype-specific markers Ctip2, Satb2, Gad1/2,
Nos1, and Pvalb did not reveal overt differences between WT
and Kdm5c-KO mice (Figure S3A). These results suggest that
Kdm5c is dispensable for gross morphogenesis of key brain
areas.
Abnormal dendritic arborization and spine morphology have
been implicated as a cellular basis of human ID and its mousers
A B
C D
Figure 2. Learning and Memory Deficiency of
Kdm5c-KO Mice
(A) In both contextual and cued fear conditioning,
Kdm5c-KO mice showed a significantly reduced
freezing response than WT in 3-min trials.
(B) KO mice showed similar response latency as WT
mice in the hot plate test for pain perception.
(C) In the Morris water maze, KOmice took longer than
WT to reach the hidden platform (*p < 0.01, repeated-
measures ANOVA). (Right panels) Representative
swim trajectory in the third trial on the third testing day.
(D) KO mice showed no defect in swimming speed.
Mean ± SEM in all panels. p values (*p < 0.05, **p <
0.005, ***p < 0.0005) are from Student’s t tests unless
noted.models (Penzes et al., 2011). We have previously shown that
Kdm5c is required for full dendritic arborization in rat cere-
bellar granular neurons in culture (Iwase et al., 2007), but the
role of Kdm5c in dendritic growth in vivo and in spine morpho-
genesis remains unknown. The basolateral amygdala (BLA)
plays a central role in perception and modulation of emotion,
including fear and aggression (Davis and Shi, 2000). Since
Kdm5c-KO mice showed abnormalities in aggression and
fear memory (Figures 1 and 2), we first determined whether
dendritic growth in the BLA is affected by Kdm5c deficiency.
Golgi staining followed by Sholl analysis showed that
Kdm5c-KO pyramidal neurons had significantly fewer den-
dritic intersections selectively in the concentric circles that
are distant from the soma (Figures 3B and 3C; 150–390 mm,
two-way ANOVA, p < 0.001), suggesting that extension and/
or branching of dendrites are affected. Indeed, dendrites of
BLA pyramidal neurons showed significantly reduced total
length (Figure 3D; Student’s t test, p < 0.0005) in the BLA of
Kdm5c-KO mice compared with that of WT littermates. More-
over, a reduced spine density, approximately 45% of WT, was
evident from proximal to distal segments of dendritic branches
in Kdm5c-KO neurons (Figure 3E). Many dendritic spines on
Kdm5c-KO neurons were noticeably thinner than those of
WT neurons and lacked mature mushroom-like morphology
(Figure 3B, lower).
To determine whether these cellular defects are specific to the
BLA, we examined the morphology of pyramidal neurons in the
motor cortex of Kdm5c-KO mice and found a slight (9%) but
significant reduction of spine density (Student’s t test, p <
0.05; Figures S3B–S3D). However, we did not find any changes
in dendritic arborization in this particular brain area (Figures S3E
and S3F). Taken together, these data demonstrate that Kdm5c
plays a role in the morphogenesis of dendrites and dendritic
spines in vivo, with a brain region-dependent sensitivity to the
loss of Kdm5c.Cell Reports 14, 1000–10Kdm5c-KO Brains Show Altered
Transcription Profiles
Kdm5c has been shown to repress neuron-
specific genes in non-neuronal cells (Tahi-
liani et al., 2007) and Myc target genes in
mouse embryonic stem (mES) cells (Out-
chkourov et al., 2013). However, thegenome-wide role of Kdm5c in the brain remains unexplored.
We therefore sought to determine the impact of Kdm5c loss on
the transcriptome of the amygdala (AMY) and frontal cortex
(FC) of adult mice, areas relevant for the Kdm5c-KO behavioral
phenotype (Figures 1, 2, S1, and S2) andwherewe had observed
defects in spine morphogenesis (Figures 3 and S3). RNA-seq
identified a comparable number of differentially expressed
genes in Kdm5c-KO amygdala (upregulated: 361, downregu-
lated: 214) and frontal cortex (up: 440, down: 252) compared
with WT brain tissues (p < 0.01; Figure 4A; Table S1). The larger
number of upregulated genes than downregulated genes is
consistent with the enzymatic activity of Kdm5c, which removes
the active chromatin marks H3K4me2/3. The overlap of differen-
tially regulated genes between the amygdala and the frontal cor-
tex (98 upregulated and 21 downregulated genes) was relatively
small. The median changes of gene expression were modest,
ranging from 1.40- to 1.52-fold (Figure 4B), suggesting that
Kdm5c has a role in fine-tuning expression of hundreds of genes.
To explore the biological significance of the altered gene
expression program in Kdm5c-KO brain areas, we used LR
path gene set enrichment program (Kim et al., 2012) to define
the gene ontologies (GOs) that were significantly mis-regulated
in at least one brain area (false discovery rate [FDR] < 0.015).
Cluster analysis of these GO terms indicated that the two brain
areas of the KO mice display largely distinct patterns of tran-
scriptional alteration. We defined four main classes based on
the hierarchical clustering of upregulation or downregulation of
GO terms in the amygdala and in the frontal cortex (Figure 4C;
Table S2). Interestingly, categories that were downregulated in
KO amygdala but unchanged in KO frontal cortex (class I) are
highly relevant for neuronal differentiation, neuron-projection
development, and synapses (Figure 4C), which is consistent
with the dendritic growth defect in Kdm5c-KO BLA (Figure 3)
but not motor cortex (Figure S3). Consistent with the more
severely reduced spine density in the amygdala, when we09, February 9, 2016 ª2016 The Authors 1003
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Figure 3. Loss of Kdm5c Resulted in Defects in Dendritic Arborization and Spine Morphology In Vivo
(A) Nissl staining of adult WT and Kdm5c-KO coronal brain sections. Grossmorphology of the brain was preserved in KOmice. A, amygdala; cc, corpus callosum;
Ctx, cerebral cortex; Hip, hippocampus; Hyp, hypothalamus; Pyr, pyriform cortex; Str, striatum; Th, thalamus. Scale bars represent 500 mm.
(B) Representative BLA pyramidal neurons visualized by Golgi staining. Scale bars represent 20 mm (upper) and 3 mm (lower). Bifurcated and mushroom-shaped
dendritic spines (red arrowheads inWT) were less evident in KO neurons. Throughout the study, 20 neurons per genotype from adult KO andWT littermates (n = 4
per genotype) were analyzed in a blind fashion.
(C) KO neurons had fewer intersections in outer concentric circles in the BLA (left, 150–390 mm, two-way ANOVA, **p < 0.05).
(D) Reduced dendritic length of BLA pyramidal neurons in KO mice.
(E) BLA pyramidal neurons of KO showed significantly lower spine density (left), whichwas seen fromproximal to distal segments (***p < 0.0005, two-way ANOVA,
right).
Mean ± SEM in all panels. p values (*p < 0.05, **p < 0.005, ***p < 0.0005) are from Student’s t tests unless noted.used ‘‘Reactome,’’ a curated biological pathway database (Croft
et al., 2014), synaptic pathways such as ‘‘Glutamate Neurotrans-
mitter Release Cycle’’ and ‘‘Nicotinic acetylcholine receptors’’
are downregulated in the KO amygdala but not in the frontal cor-
tex (Figure S4A). Categories that were upregulated inKdm5c-KO
amygdala but unchanged in the frontal cortex include GO terms
related to cilia (Figure 4C, class III), which play an important role
in neurodevelopment (Louvi and Grove, 2011). GOs showing
upregulation in the amygdala and downregulation in the frontal
cortex include behavior-related ontologies such as response to
amphetamine (Figure 4C, class IV). These data suggest that
Kdm5c loss leads to different functional consequences depend-
ing on the brain area.
To determine whether genes associated with neurodevelop-
mental disorders significantly overlap with the mis-regulated
genes inKdm5c-KO brain, we performed LR path analyses using
curated lists of genes that are associated with IDs (Gardiner,
2015), ASDs (Basu et al., 2009), and schizophrenia (Fromer
et al., 2014). Although many of these genes overlapped with
mis-regulated genes in the KO brains, we did not find statistically
significant enrichment in either the amygdala or the frontal cortex
(p = 0.37 0.93; Table S3). Collectively, mis-regulation of hun-
dreds of genes involved in neurodevelopment rather than known
humandisorder genes is likely instructive toKDM5Cdeficiencies.
Elevated aggression (Figure 1B) and a trend of higher testos-
terone levels (Figure S1F) in Kdm5c-KO mice prompted us
to examine the possibility that altered androgen levels may
mediate some of the effects of Kdm5c loss on the brain tran-1004 Cell Reports 14, 1000–1009, February 9, 2016 ª2016 The Authoscriptome. We examined the expression levels of 979 annotated
androgen-responsive genes (ARGs) (Jiang et al., 2009) as a
group in WT and Kdm5c-KO amygdala and frontal cortex, and
detected no difference as a whole (Figure S4B). However, we
did identify a statistically significant enrichment of ARGs in the
list of mis-regulated genes in the amygdala and the frontal cortex
(Figure S4C; Table S4). Enrichment was more pronounced in up-
regulated genes (chi-square test, p < 4.03 1023) than in down-
regulated genes (p < 1.4 3 103), which is consistent with a
higher testosterone level in Kdm5c-KO serum. These results
suggest that the higher testosterone level in Kdm5c-KO mice,
albeit marginally non-significant, may elicit upregulation of
ARGs in Kdm5c-KO brain and, in turn, behavioral phenotypes.
Molecular Mechanisms of Kdm5c-mediated Gene
Regulation in Neurons
To gain insight into the molecular mechanisms underlying
Kdm5c function in post-mitotic neurons, we performed inte-
grated functional genomic analysis of dissociated cortical neu-
rons isolated from the forebrain (which gives rise to brain tissues
including the cortex and amygdala) at E16.5 and harvested after
10 days of in vitro culture. This culture system allows us to inves-
tigate gene regulation by Kdm5c in a relatively homogenous
neuronal population, with minimal glial contamination (Brewer
et al., 1993).
We first determined sites of Kdm5c recruitment in post-mitotic
neurons by chromatin immunoprecipitation coupled with deep
sequencing (ChIP-seq) using an anti-Kdm5c antibody. Ourrs
AB
C
Figure 4. Altered Transcription Profiles in Kdm5c-KO Brain Tissues
RNA-seq data were obtained from the amygdala (AMY) and the frontal cortex (FC) of three adult mice for each genotype.
(A) Differentially expressed (DE) genes between WT and Kdm5c-KO brain (p < 0.01). AMY and FC show a modest overlap.
(B) KO/WT ratio of expression levels of DE genes. Box signifies the upper and lower quartiles, the interquartile range (IQR), with the median represented by a short
black line. Whiskers, 1.5 3 IQR.
(C) LR path analysis of mis-regulated GO categories followed by clustering (FDR < 0.015). The odds ratio for enrichment is shown. Yellow and blue indicate
upregulation and downregulation in KO compared with WT, respectively. Four major classes (I to IV) represent differential alteration patterns between AMY
and FC.ChIP-seq analysis identified 6,728 high-confidence Kdm5c
peaks after subtracting peaks found in the Kdm5c-KO neurons,
which constitute non-specific and low-confidence peaks. We
found that 48% and 16% of Kdm5c peaks fall within gene pro-
moters and enhancers, respectively, which represent a signifi-
cant enrichment at these two functional elements (Figures 5A
and S5A). The vast majority of Kdm5c peaks (93%) are found
within 500 bps of DNase I hypersensitivity sites (DHSs; Fig-
ure S5B), a marker of open chromatin and active cis-regulatory
elements (obtained from E14.5 and P56 mouse brains; Neph
et al., 2012), suggesting that Kdm5c modulates transcription of
active genes. At promoters, Kdm5c shows a pronounced peak
at the transcription start site (TSS; Figures 5B and S5C). We
observed a detectable but significantly lower Kdm5c ChIP signal
in Kdm5c-KO neurons (Figures 5B, S5C, and S5H), which is
probably attributable to a trace amount of Kdm5c lacking the
enzymatic domain (Figure S1D).Cell RWe noted that Kdm5c peaks often coincide with CpG islands
(Figures 5B and S5C). Genome-wide assessment reveals that
themajority of Kdm5c-bound promoters (94%) contain a CpG is-
land, representing a significant enrichment over the genomic
average (Figure 5C; p < 1 3 1026, chi-square test). Kdm5c oc-
cupies 26% of CpG-containing promoters but only 2% of non-
CpG promoters (Figure S5D). CpG island-regulated genes
encode both highly expressed housekeeping genes and tis-
sue-specific genes, and their promoters are extensively deco-
rated with H3K4me3 (Deaton and Bird, 2011). Indeed, both
mRNA and promoter H3K4me3 levels are significantly higher
for CpG island-regulated genes compared with non-CpG genes
in neurons (Figure S5E). Consistently, we found that Kdm5c
levels at target promoters are positively correlated with expres-
sion levels of corresponding genes (Figure S5F), and Kdm5c-
bound genes are enriched for middle and highly expressed
genes (Figure S5G). Even lowly expressed Kdm5c-target geneseports 14, 1000–1009, February 9, 2016 ª2016 The Authors 1005
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Figure 5. Kdm5c Is Recruited to CpG Promoters with High H3K4me3 in Post-mitotic Neurons and Represses Transcription
ChIP-seq and RNA-seq were performed on two biological replicates of WT and Kdm5c-KO neurons.
(A) Enrichment of high-confidence Kdm5c peaks in promoter and enhancer regions (left) compared with genomic fractions (right). Promoter, ± 1.5 kb of TSS;
enhancers, ± 2.0 kb of intergenic DNaseI hypersensitive sites (DHS) of E14.5 and adult brains (Neph et al., 2012); TTS, ± 1.0 kb of transcription termination sites.
(B) UCSC browser shot of Kdm5c, H3K4me3, and H3K4me1 across the Kdm5c-bound locus Slc29a1 (gray, WT; red, KO). RNA-seq in WT neurons is shown in
red; CpG island position is indicated in green.
(C) Most Kdm5c-bound promoters harbor CpG islands (left), which represents strong enrichment over the genomic average (right) (p < 1.0 3 1026, chi-square
test).
(D) Western blot analysis shows that global H3K4me levels are not altered in Kdm5c-KO neurons. Representative image is from two biological replicates.
(E) WT neurons were used to divide genes into four groups (with approximately equal numbers of genes) according to expression level. Kdm5c-bound promoters
with low expression levels show significantly higher H3K4me3 levels than unbound genes with the same expression levels.
(F and G) Expression and H3K4me3 changes inKdm5c-KO neurons.WT neurons were used to divide genes into three groups (with approximately equal numbers
of genes) according to expression level. Low-expressed Kdm5c-target genes showed the most noticeable increase in expression (median: 7% increase, p =
1.4 3 108, Wilcoxon signed rank test) and H3K4me3 (median: 12% increase, p < 2.2 3 1016, Wilcoxon signed rank test) in KO neurons.
(H) 206 differentially expressed (DE) genes in Kdm5c-KO neurons identified by RNA-seq (p < 0.025).
(I) Expression level fold change of unchanged and DE genes in KO neurons compared with WT.
(J) Overlap of Kdm5c-bound promoters with DE genes from KO/WT.
(K) Upregulated and downregulated genes showed significantly higher or lower H3K4me3 levels in Kdm5c-KO neurons, respectively (p < 2.03 105 in Wilcoxon
signed rank test).
In box plots, box signifies the upper and lower quartiles, the interquartile range (IQR), with the median represented by a short black line. Whiskers, 1.5 3 IQR.are unexpectedly marked with high H3K4me3 (Figure 5E), sug-
gesting that CpG islands and high H3K4me3 are the primary
chromatin signatures that recruit Kdm5c.
KDM5C mediates demethylation of H3K4me3 and H3K4me2
(Iwase et al., 2007; Tahiliani et al., 2007), which are generally
associated with actively transcribed genes. In neurons, global
levels of H3K4me1, H3K4me2, or H3K4me3 are comparable in
WT and Kdm5c-KO neurons (Figure 5D), suggesting that
Kdm5c is not a global regulator of H3K4 methylation. We postu-
lated that Kdm5c plays a region-specific role, acting to downre-
gulate gene transcription by removing H3K4me3 from actively
transcribed promoters. To test this hypothesis, we generated
RNA-seq and H3K4 methylation (H3K4me3, H3K4me1) ChIP-
seq data from WT and Kdm5c-KO neurons.1006 Cell Reports 14, 1000–1009, February 9, 2016 ª2016 The AuthoTo analyze the impact of Kdm5c promoter binding, we
compared mRNA and H3K4me3 levels of all Kdm5c-bound
genes in WT and Kdm5c-KO neurons and, surprisingly, did not
find any significant difference (data not shown). However,
whenwe grouped genes based on their mRNA levels, we noticed
significant upregulation of lowly expressed Kdm5c target
genes in Kdm5c-KO relative to WT neurons (Figure 5F; median:
7% increase, p = 1.43 108, Wilcoxon signed rank test). Simi-
larly, H3K4me3 levels at the lowest expressed Kdm5c targets
(±1.5 kb of TSS) were increased in Kdm5c-KO neurons (Fig-
ure 5G; median: 12% increase, p < 2.2 3 1016, Wilcoxon
signed rank test). Plotting the distribution of H3K4me3 around
the TSS for these different groups demonstrated that low,
but not middle or high, expressed Kdm5c targets showed anrs
increase in H3K4me3 at promoters (Figure S5H; p < 0.05, Stu-
dent’s t test). In contrast, H3K4me1 levels downstream of the
TSSwere higher in KO regardless of gene expression levels (Fig-
ure S5H). These data indicate that Kdm5c primarily acts as
a transcriptional co-repressor when bound at promoters and
that lowly expressed genes are more sensitive to the loss of
Kdm5c. The absence of significant mis-regulation of the majority
of Kdm5c-bound genes suggests that Kdm5c mainly plays a
fine-tuning role, which is consistent with our brain tissue RNA-
seq (Figure 4). Although we did not observe a compensatory
increase in mRNA levels of other Kdm5 family members in
Kdm5c-KO neurons (Figure S5I) or brain tissues (Figure S5J),
functional redundancy may also explain the minimal effects of
Kdm5c loss on genes with higher expression levels.
RNA-seq analysis from the neuronal cultures identified 169
upregulated and 37 downregulated genes inKdm5c-KOneurons
compared with WT (Figure 5H; p < 0.025; Table S5). We found a
considerable overlap of the differentially expressed genes in
cultured neurons with those identified from brain tissues (Fig-
ure S5K). We validated a panel of upregulated genes, including
genes that are also upregulated in the brain tissues, using quan-
titative RT-PCR (qRT-PCR) (Figure S5L). Upregulated genes that
are common to both cultured neurons and brain tissue likely
represent Kdm5c-regulated events specific to neurons rather
than other cell types present in brain tissue. Similar to brain tis-
sues, the magnitude of the gene expression changes in cultured
neurons was modest (Figure 5I; upregulated genes: 1.88-fold;
downregulated genes: 1.44-fold). When we integrated RNA-
seq and Kdm5c ChIP-seq data from cultured neurons, we found
high-confidence Kdm5c peaks at the promoters of 29.6% of
upregulated genes but only 16.2% of downregulated genes
(Figure 5J). Significantly upregulated or downregulated genes
in Kdm5c-KO neurons showed an increase or decrease of
H3K4me3, respectively, both genome-wide (Figure 5K) and at
specific loci (Figures 5B and S5C). These genome-wide data
identified mechanisms of Kdm5c-mediated gene repression,
which may account for mis-regulation of genes in vivo that are
closely associated with dendritic and behavioral deficits.
DISCUSSION
We have generated and characterized a mouse model of ID
caused by the loss-of-function of a histone demethylase. Impor-
tantly, Kdm5c-KO mice recapitulate key cognitive, adaptive,
and social abnormalities seen in patients with KDM5C muta-
tions, including increased aggression, decreased anxiety and
social behavior, and defects in learning and memory (Figures 1
and 2).
We identified a significant reduction in dendritic arborization
and spine density in the BLA (Figures 3B–3E), a region known
to be important for the formation of fear memory and for aggres-
sive behavior (Davis and Shi, 2000). Spine density in the
BLA has previously been linked to anxiety and cognitive deficits
(Leuner and Shors, 2013), suggesting that these alterations
may contribute to the behavioral phenotypes. In contrast, spine
density was slightly reduced in the cortex of Kdm5c-KO mice,
whereas dendritic arborization was unaffected (Figure S3).
Different changes in gene expression were identified inCell RKdm5c-KO amygdala and cortical brain tissues (Figure 4). Differ-
ential sensitivity to Kdm5c loss between brain areas in both
cellular phenotypes and gene expression levels emphasizes
the importance of future investigation into brain region-specific
roles of Kdm5c. We are currently carrying out a systematic anal-
ysis to localize the anatomical substrates for individual behav-
ioral phenotypes by genetically deleting Kdm5c in discrete brain
locations and in specific cell types.
Our ChIP-seq and RNA-seq analyses in cultured neurons have
provided molecular insights into how Kdm5c might regulate
neuronal function. ChIP-seq identified Kdm5c at gene promoters
characterized by the presence of CpG islands and high
H3K4me3 (Figures 5C, S5D, and S5E), raising the possibility
that these are the primary determinants for Kdm5c recruitment
to promoters in neurons. The effect of Kdm5c loss on gene
expression is more pronounced at genes with low expression
(Figure 5F), which are marked by unexpectedly high H3K4me3
levels in WT neurons (Figure 5E). High H3K4me3 at genes with
low expression is a hallmark of poised chromatin, often found
at genes required to undergo rapid activation (Margaritis and
Holstege, 2008). It would be interesting to investigate the role
of Kdm5c at poised genes, such as neuronal activity-dependent
genes (Saha et al., 2011).
Loss of Kdm5c causes both upregulation and downregulation
of gene expression, but a higher percentage of genes are upre-
gulated upon Kdm5c loss in both brain tissues and cultured neu-
rons (Figures 4A and 5H), indicating that Kdm5cmainly functions
as a transcriptional repressor. A recent report suggested that
Kdm5c can also act as a transcriptional activator, possibly by im-
pacting enhancer function in mES cells (Outchkourov et al.,
2013). We note that a considerable number of genes showed
downregulation in Kdm5c-KO neurons (Figures 4A and 5H) and
that Kdm5c binds to enhancers (Figure 5A). However, whether
downregulation of these genes is a result of loss of Kdm5c at en-
hancers that control their expression and, indeed, whether
Kdm5c regulates enhancer activities in neurons remain to be
investigated.
We foundmultiple key pathways that play essential roles in the
development and function of neuronal circuitry to be aberrantly
expressed in the Kdm5c-KO brain (Figure 4C). Importantly, the
differential severity of dendritic phenotypes between amygdala
and cortex correlates with the downregulation of neurodevelop-
mental pathways, lending support to the hypothesis that these
downregulated genes contribute to the dendritic morphologies
in Kdm5c-KO brains (Figure 4). Other mis-regulated pathways
include ‘‘Cilium,’’ ‘‘Dopamine receptor signaling pathway,’’
‘‘Glutamate neurotransmitter release cycle,’’ ‘‘Nicotinic acetyl-
choline receptors,’’ and ‘‘GABA receptor activation’’ (Figures 4
and S4A; Table S2), suggesting that the loss of Kdm5c may
have impact on cilia function and diverse neurotransmitter sys-
tems in a brain area-dependent manner. Thus, our transcriptome
analyses provide a useful resource for future investigations to
determine the downstream effector genes responsible for
phenotypic outcomes in this unique mouse model of ID.
Although the magnitude of gene mis-regulation in Kdm5c-KO
neurons ismodest (Figures 4B and 5I), it is possible that an accu-
mulation of small changes in multiple pathways may collectively
contribute to the observed behavioral and cellular abnormalities.eports 14, 1000–1009, February 9, 2016 ª2016 The Authors 1007
Alternatively, specific deficits may be attributable to a single re-
ceptor-mediated pathway in a brain region- and/or circuitry-spe-
cific fashion. In addition, it remains to be determined whether
there is a critical period for Kdm5c function during development.
Therefore, it will be important in the future to employ pharmaco-
logical and genetic approaches to determine (1) whether the
behavioral and cellular deficits originate during development
and (2) the functional significance of Kdm5c target genes for their
contributions to the phenotypes associated with the loss of
Kdm5c. In conclusion, our mouse model of XLID caused by mu-
tations in KDM5C provides insights into the fundamental mech-
anisms by which histone methylation dynamics sculpt the
neuronal network and a foundation for strategizing future XLID
therapies.
EXPERIMENTAL PROCEDURES
Gene targeting was carried out in a 129-derived mES cell line. After germline
deletion of floxed segment using B6.C-Tg(CMV-cre)1Cgn/J mice (The Jackson
Laboratory), the knockout allele was maintained on a C57BL/6J background
(The Jackson Laboratory) with more than nine generations of backcrossing,
thereby eliminating 129 genetic background. Tominimize phenotypic variability
due to heterogeneous genetic background, we compared F1 littermates gener-
ated from breeding between a heterozygous KO female on the C57BL/6J back-
ground and a WT 129S1/SvImJ male (The Jackson Laboratory) throughout the
present study (Silva et al., 1997). Behavioral paradigms were performed ac-
cording to standard protocols and in a blind fashion. Morphological analyses
of dendrites were carried out as described previously (Shmelkov et al., 2010).
RNA-seq libraries were prepared from the frontal cortex and the amygdala of
adult (3 to 6 months) mice and from cultured neurons after 9–10 days in vitro,
according to method described previously (Agarwal et al., 2015). RNA-seq
and ChIP-seq libraries were sequenced on an Illumina HiSeq 2000 system; re-
sulting reads were mapped and analyzed as described in supplementary
methods.
Animals
Animal procedures were approved by institutional animal care and use com-
mittees of Boston Children’s Hospital (13-08-2474R), Washington State Uni-
versity (04298), and the University of Michigan (PRO00004174).
ACCESSION NUMBERS
RNA-seq and ChIP-seq data are available in the Gene Expression Omnibus
under accession number GEO: GSE61036.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, five tables, and two movies and can be found with this article on-
line at http://dx.doi.org/10.1016/j.celrep.2015.12.091.
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